These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9160320)

  • 1. Cytoplasmic biotin-like activity interferes with immunohistochemical analysis of thyroid lesions: a comparison of antigen retrieval methods.
    Kashima K; Yokoyama S; Daa T; Nakayama I; Nickerson PA; Noguchi S
    Mod Pathol; 1997 May; 10(5):515-9. PubMed ID: 9160320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique.
    Figge J; Bakst G; Weisheit D; Solis O; Ross JS
    Am J Pathol; 1991 Dec; 139(6):1213-9. PubMed ID: 1721488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of acidic and basic fibroblast growth factors in human benign and malignant thyroid lesions.
    Kodama M; Daa T; Kashima K; Yokoyama S; Nakayama I; Noguchi S
    Jpn J Clin Oncol; 1994 Apr; 24(2):66-73. PubMed ID: 7512670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma.
    Sack MJ; Astengo-Osuna C; Lin BT; Battifora H; LiVolsi VA
    Mod Pathol; 1997 Jul; 10(7):668-74. PubMed ID: 9237176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostaining for Leu-7 in the diagnosis of thyroid carcinoma.
    Loy TS; Darkow GV; Spollen LE; Diaz-Arias AA
    Arch Pathol Lab Med; 1994 Feb; 118(2):172-4. PubMed ID: 7508715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining for thyroglobulin in poorly differentiated carcinoma of the thyroid.
    Ratnatnga N; Ramadasa S
    Ceylon Med J; 1993 Sep; 38(3):113-6. PubMed ID: 7828228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
    Nasser SM; Pitman MB; Pilch BZ; Faquin WC
    Cancer; 2000 Oct; 90(5):307-11. PubMed ID: 11038428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HBME-1 immunostaining in thyroid pathology].
    Rigau V; Martel B; Evrard C; Rousselot P; Galateau-Salle F
    Ann Pathol; 2001 Feb; 21(1):15-20. PubMed ID: 11223556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
    Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
    Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining for P-glycoprotein in the diagnosis of thyroid carcinomas.
    Loy TS; Gelven PL; Mullins D; Diaz-Arias AA
    Mod Pathol; 1992 Mar; 5(2):200-2. PubMed ID: 1374189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
    Lewy-Trenda I; Wierzchniewska-Ławska A
    Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
    J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.
    Cvejic D; Savin S; Paunovic I; Tatic S; Havelka M; Sinadinovic J
    Anticancer Res; 1998; 18(4A):2637-41. PubMed ID: 9703921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
    Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
    Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma.
    Barranco C; Mate JL; Ariza A; Baró T; Díaz E; Munné A; Serrano S
    Mod Pathol; 2003 Feb; 16(2):161-5. PubMed ID: 12591969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
    Kavishwar VS; Phatak AM; Rege JD
    Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estrogen receptors in the malignant and benign neoplasms of the thyroid].
    Lewy-Trenda I
    Pol Merkur Lekarski; 1998 Aug; 5(26):80-3. PubMed ID: 10101461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
    Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
    Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
    Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
    Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.